Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Impax Laboratories, LLC | c12986e10vk.htm |
| EX-31.1 - EXHIBIT 31.1 - Impax Laboratories, LLC | c12986exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - Impax Laboratories, LLC | c12986exv31w2.htm |
| EX-32.1 - EXHIBIT 32.1 - Impax Laboratories, LLC | c12986exv32w1.htm |
| EX-32.2 - EXHIBIT 32.2 - Impax Laboratories, LLC | c12986exv32w2.htm |
| EX-21.1 - EXHIBIT 21.1 - Impax Laboratories, LLC | c12986exv21w1.htm |
| EX-10.15 - EXHIBIT 10.15 - Impax Laboratories, LLC | c12986exv10w15.htm |
| EX-10.14 - EXHIBIT 10.14 - Impax Laboratories, LLC | c12986exv10w14.htm |
| EX-10.1.8 - EXHIBIT 10.1.8 - Impax Laboratories, LLC | c12986exv10w1w8.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We have issued our reports dated February 25, 2011, with respect to the consolidated financial
statements, schedule, and internal control over financial reporting included in the Annual Report
of Impax Laboratories, Inc. and Subsidiaries on Form 10-K for the year ended December 31, 2010. We
hereby consent to the incorporation by reference of said reports in
the Registration Statements of
Impax Laboratories, Inc. and Subsidiaries on Form S-8 (File No. 333-158259 effective March 27, 2009
and File No. 333-168584 effective August 6, 2010).
/s/ GRANT THORNTON LLP
Philadelphia, Pennsylvania
February 25, 2011
February 25, 2011